aluates Reports

$ 0.0

Automative

Global Viral and Non-viral Vector Market Research Report 2026

Published Date: 2026-01-21

Report Code: QYRE-Auto-33B18628

Global Viral and Non viral Vector Market Research Report 2024

BUY CHAPTERS

Global Viral and Non-viral Vector Market Research Report 2026

Code: QYRE-Auto-33B18628

Report

2026-01-21

Pages:117

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher Scientific

Oxford BioMedica

Lonza

Genewiz

Revvity

VectorBuilder

OBiO Technology

Takara Bio

Genscript Biotech

GENE Chem

PackGene Biotech

Virovek

Geno Meditech

Viral and Non-viral Vector Market Size

The global Viral and Non-viral Vector market was valued at US$ 970 million in 2025 and is anticipated to reach US$ 2284 million by 2032, at a CAGR of 13.2% from 2026 to 2032.

Viral and Non-viral Vector Market

Viral and non-viral vectors are delivery systems used to transfer genetic material into cells for therapeutic or research purposes. Viral vectors are modified viruses engineered to carry and deliver specific genes, taking advantage of their natural ability to infect cells. Common examples include adenoviruses, lentiviruses, and adeno-associated viruses (AAV). Non-viral vectors, on the other hand, are synthetic or naturally derived systems that do not rely on viruses. These include liposomes, nanoparticles, electroporation, and plasmid DNA. While viral vectors offer high efficiency in gene delivery, non-viral vectors are often preferred for their lower immunogenicity, easier production, and enhanced safety profiles.

The North American market for Viral and Non-viral Vector is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Viral and Non-viral Vector is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Viral and Non-viral Vector in Pharmaceutical and Biopharmaceutical Companies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Viral and Non-viral Vector include Thermo Fisher Scientific, Oxford BioMedica, Lonza, GENEWIZ, Revvity, VectorBuilder, OBIO Technology, Takara Bio, GenScript Biotech, Gene Chem, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Viral and Non-viral Vector market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Viral and Non-viral Vector. The Viral and Non-viral Vector market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Viral and Non-viral Vector market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Viral and Non-viral Vector manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Viral and Non-viral Vector Market Report

Report Metric	Details
Report Name	Viral and Non-viral Vector Market
Accounted market size in 2025	US$ 970 million
Forecasted market size in 2032	US$ 2284 million
CAGR	13.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	AAV Lentiviruses Retroviruses Adenoviruses DNA Plasmids Others
Segment by Application	Pharmaceutical and Biopharmaceutical Companies Academics and Research Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Oxford BioMedica, Lonza, GENEWIZ, Revvity, VectorBuilder, OBIO Technology, Takara Bio, GenScript Biotech, Gene Chem, Geno Meditech, PackGene Biotech, VIROVEK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Viral and Non-viral Vector companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Viral and Non-viral Vector Market growing?

Ans: The Viral and Non-viral Vector Market witnessing a CAGR of 13.2% during the forecast period 2026-2032.

What is the Viral and Non-viral Vector Market size in 2032?

Ans: The Viral and Non-viral Vector Market size in 2032 will be US$ 2284 million.

Who are the main players in the Viral and Non-viral Vector Market report?

Ans: The main players in the Viral and Non-viral Vector Market are Thermo Fisher Scientific, Oxford BioMedica, Lonza, GENEWIZ, Revvity, VectorBuilder, OBIO Technology, Takara Bio, GenScript Biotech, Gene Chem, Geno Meditech, PackGene Biotech, VIROVEK

What are the Application segmentation covered in the Viral and Non-viral Vector Market report?

Ans: The Applications covered in the Viral and Non-viral Vector Market report are Pharmaceutical and Biopharmaceutical Companies, Academics and Research Institutes, Others

What are the Type segmentation covered in the Viral and Non-viral Vector Market report?

Ans: The Types covered in the Viral and Non-viral Vector Market report are AAV, Lentiviruses, Retroviruses, Adenoviruses, DNA Plasmids, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Viral and Non-viral Vector Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 AAV

1.2.3 Lentiviruses

1.2.4 Retroviruses

1.2.5 Adenoviruses

1.2.6 DNA Plasmids

1.2.7 Others

1.3 Market by Application

1.3.1 Global Viral and Non-viral Vector Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Pharmaceutical and Biopharmaceutical Companies

1.3.3 Academics and Research Institutes

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Viral and Non-viral Vector Market Perspective (2021–2032)

2.2 Global Viral and Non-viral Vector Growth Trends by Region

2.2.1 Global Viral and Non-viral Vector Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Viral and Non-viral Vector Historic Market Size by Region (2021–2026)

2.2.3 Viral and Non-viral Vector Forecasted Market Size by Region (2027–2032)

2.3 Viral and Non-viral Vector Market Dynamics

2.3.1 Viral and Non-viral Vector Industry Trends

2.3.2 Viral and Non-viral Vector Market Drivers

2.3.3 Viral and Non-viral Vector Market Challenges

2.3.4 Viral and Non-viral Vector Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Viral and Non-viral Vector Players by Revenue

3.1.1 Global Top Viral and Non-viral Vector Players by Revenue (2021–2026)

3.1.2 Global Viral and Non-viral Vector Revenue Market Share by Players (2021–2026)

3.2 Global Top Viral and Non-viral Vector Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Viral and Non-viral Vector Revenue

3.4 Global Viral and Non-viral Vector Market Concentration Ratio

3.4.1 Global Viral and Non-viral Vector Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Viral and Non-viral Vector Revenue in 2025

3.5 Global Key Players of Viral and Non-viral Vector Head Offices and Areas Served

3.6 Global Key Players of Viral and Non-viral Vector, Products and Applications

3.7 Global Key Players of Viral and Non-viral Vector, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Viral and Non-viral Vector Breakdown Data by Type

4.1 Global Viral and Non-viral Vector Historic Market Size by Type (2021–2026)

4.2 Global Viral and Non-viral Vector Forecasted Market Size by Type (2027–2032)

5 Viral and Non-viral Vector Breakdown Data by Application

5.1 Global Viral and Non-viral Vector Historic Market Size by Application (2021–2026)

5.2 Global Viral and Non-viral Vector Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Viral and Non-viral Vector Market Size (2021–2032)

6.2 North America Viral and Non-viral Vector Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Viral and Non-viral Vector Market Size by Country (2021–2026)

6.4 North America Viral and Non-viral Vector Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Viral and Non-viral Vector Market Size (2021–2032)

7.2 Europe Viral and Non-viral Vector Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Viral and Non-viral Vector Market Size by Country (2021–2026)

7.4 Europe Viral and Non-viral Vector Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Viral and Non-viral Vector Market Size (2021–2032)

8.2 Asia-Pacific Viral and Non-viral Vector Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Viral and Non-viral Vector Market Size by Region (2021–2026)

8.4 Asia-Pacific Viral and Non-viral Vector Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Viral and Non-viral Vector Market Size (2021–2032)

9.2 Latin America Viral and Non-viral Vector Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Viral and Non-viral Vector Market Size by Country (2021–2026)

9.4 Latin America Viral and Non-viral Vector Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Viral and Non-viral Vector Market Size (2021–2032)

10.2 Middle East & Africa Viral and Non-viral Vector Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Viral and Non-viral Vector Market Size by Country (2021–2026)

10.4 Middle East & Africa Viral and Non-viral Vector Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Viral and Non-viral Vector Introduction

11.1.4 Thermo Fisher Scientific Revenue in Viral and Non-viral Vector Business (2021–2026)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Oxford BioMedica

11.2.1 Oxford BioMedica Company Details

11.2.2 Oxford BioMedica Business Overview

11.2.3 Oxford BioMedica Viral and Non-viral Vector Introduction

11.2.4 Oxford BioMedica Revenue in Viral and Non-viral Vector Business (2021–2026)

11.2.5 Oxford BioMedica Recent Development

11.3 Lonza

11.3.1 Lonza Company Details

11.3.2 Lonza Business Overview

11.3.3 Lonza Viral and Non-viral Vector Introduction

11.3.4 Lonza Revenue in Viral and Non-viral Vector Business (2021–2026)

11.3.5 Lonza Recent Development

11.4 GENEWIZ

11.4.1 GENEWIZ Company Details

11.4.2 GENEWIZ Business Overview

11.4.3 GENEWIZ Viral and Non-viral Vector Introduction

11.4.4 GENEWIZ Revenue in Viral and Non-viral Vector Business (2021–2026)

11.4.5 GENEWIZ Recent Development

11.5 Revvity

11.5.1 Revvity Company Details

11.5.2 Revvity Business Overview

11.5.3 Revvity Viral and Non-viral Vector Introduction

11.5.4 Revvity Revenue in Viral and Non-viral Vector Business (2021–2026)

11.5.5 Revvity Recent Development

11.6 VectorBuilder

11.6.1 VectorBuilder Company Details

11.6.2 VectorBuilder Business Overview

11.6.3 VectorBuilder Viral and Non-viral Vector Introduction

11.6.4 VectorBuilder Revenue in Viral and Non-viral Vector Business (2021–2026)

11.6.5 VectorBuilder Recent Development

11.7 OBIO Technology

11.7.1 OBIO Technology Company Details

11.7.2 OBIO Technology Business Overview

11.7.3 OBIO Technology Viral and Non-viral Vector Introduction

11.7.4 OBIO Technology Revenue in Viral and Non-viral Vector Business (2021–2026)

11.7.5 OBIO Technology Recent Development

11.8 Takara Bio

11.8.1 Takara Bio Company Details

11.8.2 Takara Bio Business Overview

11.8.3 Takara Bio Viral and Non-viral Vector Introduction

11.8.4 Takara Bio Revenue in Viral and Non-viral Vector Business (2021–2026)

11.8.5 Takara Bio Recent Development

11.9 GenScript Biotech

11.9.1 GenScript Biotech Company Details

11.9.2 GenScript Biotech Business Overview

11.9.3 GenScript Biotech Viral and Non-viral Vector Introduction

11.9.4 GenScript Biotech Revenue in Viral and Non-viral Vector Business (2021–2026)

11.9.5 GenScript Biotech Recent Development

11.10 Gene Chem

11.10.1 Gene Chem Company Details

11.10.2 Gene Chem Business Overview

11.10.3 Gene Chem Viral and Non-viral Vector Introduction

11.10.4 Gene Chem Revenue in Viral and Non-viral Vector Business (2021–2026)

11.10.5 Gene Chem Recent Development

11.11 Geno Meditech

11.11.1 Geno Meditech Company Details

11.11.2 Geno Meditech Business Overview

11.11.3 Geno Meditech Viral and Non-viral Vector Introduction

11.11.4 Geno Meditech Revenue in Viral and Non-viral Vector Business (2021–2026)

11.11.5 Geno Meditech Recent Development

11.12 PackGene Biotech

11.12.1 PackGene Biotech Company Details

11.12.2 PackGene Biotech Business Overview

11.12.3 PackGene Biotech Viral and Non-viral Vector Introduction

11.12.4 PackGene Biotech Revenue in Viral and Non-viral Vector Business (2021–2026)

11.12.5 PackGene Biotech Recent Development

11.13 VIROVEK

11.13.1 VIROVEK Company Details

11.13.2 VIROVEK Business Overview

11.13.3 VIROVEK Viral and Non-viral Vector Introduction

11.13.4 VIROVEK Revenue in Viral and Non-viral Vector Business (2021–2026)

11.13.5 VIROVEK Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Oxford BioMedica

Lonza

Genewiz

Revvity

VectorBuilder

OBiO Technology

Takara Bio

Genscript Biotech

GENE Chem

PackGene Biotech

Virovek

Geno Meditech

List of Tables

Table 1. Global Viral and Non-viral Vector Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of AAV

Table 3. Key Players of Lentiviruses

Table 4. Key Players of Retroviruses

Table 5. Key Players of Adenoviruses

Table 6. Key Players of DNA Plasmids

Table 7. Key Players of Others

Table 8. Global Viral and Non-viral Vector Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Viral and Non-viral Vector Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global Viral and Non-viral Vector Market Size by Region (US$ Million), 2021–2026

Table 11. Global Viral and Non-viral Vector Market Share by Region (2021–2026)

Table 12. Global Viral and Non-viral Vector Forecasted Market Size by Region (US$ Million), 2027–2032

Table 13. Global Viral and Non-viral Vector Market Share by Region (2027–2032)

Table 14. Viral and Non-viral Vector Market Trends

Table 15. Viral and Non-viral Vector Market Drivers

Table 16. Viral and Non-viral Vector Market Challenges

Table 17. Viral and Non-viral Vector Market Restraints

Table 18. Global Viral and Non-viral Vector Revenue by Players (US$ Million), 2021–2026

Table 19. Global Viral and Non-viral Vector Market Share by Players (2021–2026)

Table 20. Global Top Viral and Non-viral Vector Players by Tier (Tier 1, Tier 2, and Tier 3), based on Viral and Non-viral Vector Revenue, 2025

Table 21. Ranking of Global Top Viral and Non-viral Vector Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Viral and Non-viral Vector Revenue (CR5 and HHI), 2021–2026

Table 23. Global Key Players of Viral and Non-viral Vector, Headquarters and Area Served

Table 24. Global Key Players of Viral and Non-viral Vector, Products and Applications

Table 25. Global Key Players of Viral and Non-viral Vector, Date of General Availability (GA)

Table 26. Mergers and Acquisitions, Expansion Plans

Table 27. Global Viral and Non-viral Vector Market Size by Type (US$ Million), 2021–2026

Table 28. Global Viral and Non-viral Vector Revenue Market Share by Type (2021–2026)

Table 29. Global Viral and Non-viral Vector Forecasted Market Size by Type (US$ Million), 2027–2032

Table 30. Global Viral and Non-viral Vector Revenue Market Share by Type (2027–2032)

Table 31. Global Viral and Non-viral Vector Market Size by Application (US$ Million), 2021–2026

Table 32. Global Viral and Non-viral Vector Revenue Market Share by Application (2021–2026)

Table 33. Global Viral and Non-viral Vector Forecasted Market Size by Application (US$ Million), 2027–2032

Table 34. Global Viral and Non-viral Vector Revenue Market Share by Application (2027–2032)

Table 35. North America Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. North America Viral and Non-viral Vector Market Size by Country (US$ Million), 2021–2026

Table 37. North America Viral and Non-viral Vector Market Size by Country (US$ Million), 2027–2032

Table 38. Europe Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 39. Europe Viral and Non-viral Vector Market Size by Country (US$ Million), 2021–2026

Table 40. Europe Viral and Non-viral Vector Market Size by Country (US$ Million), 2027–2032

Table 41. Asia-Pacific Viral and Non-viral Vector Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 42. Asia-Pacific Viral and Non-viral Vector Market Size by Region (US$ Million), 2021–2026

Table 43. Asia-Pacific Viral and Non-viral Vector Market Size by Region (US$ Million), 2027–2032

Table 44. Latin America Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Latin America Viral and Non-viral Vector Market Size by Country (US$ Million), 2021–2026

Table 46. Latin America Viral and Non-viral Vector Market Size by Country (US$ Million), 2027–2032

Table 47. Middle East & Africa Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 48. Middle East & Africa Viral and Non-viral Vector Market Size by Country (US$ Million), 2021–2026

Table 49. Middle East & Africa Viral and Non-viral Vector Market Size by Country (US$ Million), 2027–2032

Table 50. Thermo Fisher Scientific Company Details

Table 51. Thermo Fisher Scientific Business Overview

Table 52. Thermo Fisher Scientific Viral and Non-viral Vector Product

Table 53. Thermo Fisher Scientific Revenue in Viral and Non-viral Vector Business (US$ Million), 2021–2026

Table 54. Thermo Fisher Scientific Recent Development

Table 55. Oxford BioMedica Company Details

Table 56. Oxford BioMedica Business Overview

Table 57. Oxford BioMedica Viral and Non-viral Vector Product

Table 58. Oxford BioMedica Revenue in Viral and Non-viral Vector Business (US$ Million), 2021–2026

Table 59. Oxford BioMedica Recent Development

Table 60. Lonza Company Details

Table 61. Lonza Business Overview

Table 62. Lonza Viral and Non-viral Vector Product

Table 63. Lonza Revenue in Viral and Non-viral Vector Business (US$ Million), 2021–2026

Table 64. Lonza Recent Development

Table 65. GENEWIZ Company Details

Table 66. GENEWIZ Business Overview

Table 67. GENEWIZ Viral and Non-viral Vector Product

Table 68. GENEWIZ Revenue in Viral and Non-viral Vector Business (US$ Million), 2021–2026

Table 69. GENEWIZ Recent Development

Table 70. Revvity Company Details

Table 71. Revvity Business Overview

Table 72. Revvity Viral and Non-viral Vector Product

Table 73. Revvity Revenue in Viral and Non-viral Vector Business (US$ Million), 2021–2026

Table 74. Revvity Recent Development

Table 75. VectorBuilder Company Details

Table 76. VectorBuilder Business Overview

Table 77. VectorBuilder Viral and Non-viral Vector Product

Table 78. VectorBuilder Revenue in Viral and Non-viral Vector Business (US$ Million), 2021–2026

Table 79. VectorBuilder Recent Development

Table 80. OBIO Technology Company Details

Table 81. OBIO Technology Business Overview

Table 82. OBIO Technology Viral and Non-viral Vector Product

Table 83. OBIO Technology Revenue in Viral and Non-viral Vector Business (US$ Million), 2021–2026

Table 84. OBIO Technology Recent Development

Table 85. Takara Bio Company Details

Table 86. Takara Bio Business Overview

Table 87. Takara Bio Viral and Non-viral Vector Product

Table 88. Takara Bio Revenue in Viral and Non-viral Vector Business (US$ Million), 2021–2026

Table 89. Takara Bio Recent Development

Table 90. GenScript Biotech Company Details

Table 91. GenScript Biotech Business Overview

Table 92. GenScript Biotech Viral and Non-viral Vector Product

Table 93. GenScript Biotech Revenue in Viral and Non-viral Vector Business (US$ Million), 2021–2026

Table 94. GenScript Biotech Recent Development

Table 95. Gene Chem Company Details

Table 96. Gene Chem Business Overview

Table 97. Gene Chem Viral and Non-viral Vector Product

Table 98. Gene Chem Revenue in Viral and Non-viral Vector Business (US$ Million), 2021–2026

Table 99. Gene Chem Recent Development

Table 100. Geno Meditech Company Details

Table 101. Geno Meditech Business Overview

Table 102. Geno Meditech Viral and Non-viral Vector Product

Table 103. Geno Meditech Revenue in Viral and Non-viral Vector Business (US$ Million), 2021–2026

Table 104. Geno Meditech Recent Development

Table 105. PackGene Biotech Company Details

Table 106. PackGene Biotech Business Overview

Table 107. PackGene Biotech Viral and Non-viral Vector Product

Table 108. PackGene Biotech Revenue in Viral and Non-viral Vector Business (US$ Million), 2021–2026

Table 109. PackGene Biotech Recent Development

Table 110. VIROVEK Company Details

Table 111. VIROVEK Business Overview

Table 112. VIROVEK Viral and Non-viral Vector Product

Table 113. VIROVEK Revenue in Viral and Non-viral Vector Business (US$ Million), 2021–2026

Table 114. VIROVEK Recent Development

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

Table 118. Authors List of This Report

List of Figures

Figure 1. Viral and Non-viral Vector Picture

Figure 2. Global Viral and Non-viral Vector Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Viral and Non-viral Vector Market Share by Type: 2025 vs 2032

Figure 4. AAV Features

Figure 5. Lentiviruses Features

Figure 6. Retroviruses Features

Figure 7. Adenoviruses Features

Figure 8. DNA Plasmids Features

Figure 9. Others Features

Figure 10. Global Viral and Non-viral Vector Market Size by Application (US$ Million), 2021–2032

Figure 11. Global Viral and Non-viral Vector Market Share by Application: 2025 vs 2032

Figure 12. Pharmaceutical and Biopharmaceutical Companies Case Studies

Figure 13. Academics and Research Institutes Case Studies

Figure 14. Others Case Studies

Figure 15. Viral and Non-viral Vector Report Years Considered

Figure 16. Global Viral and Non-viral Vector Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 17. Global Viral and Non-viral Vector Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Viral and Non-viral Vector Market Share by Region: 2025 vs 2032

Figure 19. Global Viral and Non-viral Vector Market Share by Players in 2025

Figure 20. Global Viral and Non-viral Vector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. The Top 10 and 5 Players Market Share by Viral and Non-viral Vector Revenue in 2025

Figure 22. North America Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. North America Viral and Non-viral Vector Market Share by Country (2021–2032)

Figure 24. United States Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Canada Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Viral and Non-viral Vector Market Share by Country (2021–2032)

Figure 28. Germany Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. France Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. U.K. Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Italy Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Russia Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Ireland Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Viral and Non-viral Vector Market Share by Region (2021–2032)

Figure 36. China Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Japan Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. South Korea Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Southeast Asia Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. India Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Australia & New Zealand Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Viral and Non-viral Vector Market Share by Country (2021–2032)

Figure 44. Mexico Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Brazil Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Viral and Non-viral Vector Market Share by Country (2021–2032)

Figure 48. Israel Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Saudi Arabia Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. UAE Viral and Non-viral Vector Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Viral and Non-viral Vector Business (2021–2026)

Figure 52. Oxford BioMedica Revenue Growth Rate in Viral and Non-viral Vector Business (2021–2026)

Figure 53. Lonza Revenue Growth Rate in Viral and Non-viral Vector Business (2021–2026)

Figure 54. GENEWIZ Revenue Growth Rate in Viral and Non-viral Vector Business (2021–2026)

Figure 55. Revvity Revenue Growth Rate in Viral and Non-viral Vector Business (2021–2026)

Figure 56. VectorBuilder Revenue Growth Rate in Viral and Non-viral Vector Business (2021–2026)

Figure 57. OBIO Technology Revenue Growth Rate in Viral and Non-viral Vector Business (2021–2026)

Figure 58. Takara Bio Revenue Growth Rate in Viral and Non-viral Vector Business (2021–2026)

Figure 59. GenScript Biotech Revenue Growth Rate in Viral and Non-viral Vector Business (2021–2026)

Figure 60. Gene Chem Revenue Growth Rate in Viral and Non-viral Vector Business (2021–2026)

Figure 61. Geno Meditech Revenue Growth Rate in Viral and Non-viral Vector Business (2021–2026)

Figure 62. PackGene Biotech Revenue Growth Rate in Viral and Non-viral Vector Business (2021–2026)

Figure 63. VIROVEK Revenue Growth Rate in Viral and Non-viral Vector Business (2021–2026)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Gene Therapy Viral Vector and Plasmid DNA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vector Based Gene Therapy Drugs Market Research Report 2024

Global Viral Vectors Non Viral Vectors and Gene Therapy Manufacturing Market Research Report 2024

Global AAV Vector Gene Therapy Market Research Report 2024

Global Viral Vector Manufacturing Market Research Report 2024

Viral Vector Production Research use Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adeno Associated Virus AAV Vector Based Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vector Manufacturing for Gene Therapy Market Research Report 2024

Viral Vector and Plasmid DNA Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AAV based Gene Therapy Products Market Research Report 2024

Global Non viral Vectors Gene Therapy Market Research Report 2025

Global Gene Delivery Technologies Market Research Report 2024

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global AAV Gene Therapy Drugs Market Research Report 2024

Global AAV Vector Based Gene Therapy Drugs Market Research Report 2024

Lentivirus Particle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Delivery or Gene Therapy Drug Market Research Report 2025

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2025

Viral Vector and Plasmid DNA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions